Compare UP & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UP | HROW |
|---|---|---|
| Founded | 2013 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | N/A | N/A |
| Metric | UP | HROW |
|---|---|---|
| Price | $0.64 | $47.90 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $68.86 |
| AVG Volume (30 Days) | ★ 3.5M | 562.9K |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $757,468,000.00 | $250,042,000.00 |
| Revenue This Year | $174.46 | $38.96 |
| Revenue Next Year | N/A | $43.38 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 47.83 |
| 52 Week Low | $0.56 | $20.85 |
| 52 Week High | $3.50 | $51.53 |
| Indicator | UP | HROW |
|---|---|---|
| Relative Strength Index (RSI) | 41.18 | 55.55 |
| Support Level | $0.56 | $44.19 |
| Resistance Level | $0.78 | $51.53 |
| Average True Range (ATR) | 0.08 | 2.31 |
| MACD | 0.02 | -0.13 |
| Stochastic Oscillator | 32.15 | 52.16 |
Wheels Up Experience Inc is a provider of on-demand private aviation in the United States. It is pioneering data and technology-driven solutions that connect consumers to safety-vetted and verified private aircraft. It connects private flyers to aircraft, and one another, through an open platform that enables life's most important experiences. Its offering is delivered through a mix of programmatic and charter options that strategically utilize its owned and leased aircraft fleet and an "asset-light" charter model to deliver a greater range of global travel alternatives. The company operates in a single operating and reportable segment, private aviation services. Geographically the company generates the majority of its revenue from the United States.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.